Outsourcing is one of the biggest global trends in the biopharmaceutical industry. It is taking more and more specific know-how to master the challenges posed by manufacturing of biologics. This includes rising prices and the need for cost reduction as well as the absolute necessity for flexibility and at least the ever shifting and in most cases increasing regulatory issues for biomanufacturing. This contribution provides a brief overview of trends and future challenges in biomanufacturing and how a contract manufacturing organisation with many years of experience positioning itself to tackle these challenges.
